Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHARE: Short Course Amoxicillin for Erysipelas
NCT01059123Phase 4Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin in erysipelas (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Clinical cure rate defined as body temperature ≤ 37.5°C and disappearance of the cutaneous plaque at Day 30. Started Sep 2010; status: terminated.
02
Drugs
amoxicillin
03
Conditions
erysipelas
Beyond the preview
Go deeper on NCT01059123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059123.